• Facebook
  • Twitter
Cancer World Archive
  • Magazine
HomeDrug WatchNo-name heroes can save Europe billions

No-name heroes can save Europe billions

Anna Wagstaff

1 March 2007 Drug Watch 0

Number 17

Download pdf article

European countries struggle to fund new cancer drugs which bring benefits at a high price. Meanwhile billions of euros are wasted, say researchers, because doctors prescribe branded drugs when a generic equivalent is just as good, and because the cost of generics is far too high.

Download full article

  • branded drugs
  • cancer drugs
  • drug budgets
  • generic drugs
Previous article
Next article

Related Articles

Senza categoria

Health rationing in Europe: can cancer get a fair hearing?

Senza categoria 1 May 2009 0
Editorial

Fake drugs pose a threat to Europe’s cancer patients

Editorial 1 November 2010 0
News

New cancer drugs may not work the way scientists thought

News 14 October 2019 0

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy